https://www.selleckchem.com/products/ms-275.html
Direct oral anticoagulants (DOACs) are increasingly prescribed instead of warfarin for chronic anticoagulation for ease of dosing, fewer interactions, and less stringent monitoring. However, it is important to consider indications and comorbidities for which warfarin is still the preferred anticoagulant. This review aims to capture these clinical scenarios in which warfarin may still be preferred over DOACs. We undertook a comprehensive literature search using the PubMed database. Key search terms were based on DOAC clinical trial exclus